MPM BIOVENTURES 2018, L.P. sold 6.3% of their position (259.84K shares) of ENTRADA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.91M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/9/2026ACC: 0001231919-26-001156
10% Owner
Since Oct 2021
-259.84K
Net shares
Net seller
$1.91M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
259.84K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−38.50K
Price / share
$7.11
Trade value
$273.74K
% of position
0.9%
9/4/2026
4.14M→4.11M
Common Stock
Indirect
Shares
−192.50K
Price / share
$7.41
Trade value
$1.43M
% of position
4.7%
9/8/2026
4.11M→3.91M
Common Stock
Indirect
Shares
−28.84K
Price / share
$7.13
Trade value
$205.61K
% of position
0.7%
9/9/2026
3.91M→3.89M
Total
Net shares
−259.84K
Net value
-$1.91M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/4/2026 | S · Sale | −38.50K | $7.11 | $273.74K | 0.9% | 4.14M | 4.11M |
| Common Stock Indirect | 9/8/2026 | S · Sale | −192.50K | $7.41 | $1.43M | 4.7% | 4.11M | 3.91M |
| Common Stock Indirect | 9/9/2026 | S · Sale | −28.84K | $7.13 | $205.61K | 0.7% | 3.91M | 3.89M |
| Total | −259.84K | -$1.91M | ||||||
Derivative Transactions0
No derivative transactions reported